HealthApr 1, 2026FDA approves Foundayo (orforglipron), Eli Lilly’s once-daily oral obesity medicationThe Food and Drug Administration has approved Foundayo, a once-daily oral obesity medication from Eli Lilly whose active ingredient is orforglipron, a non-peptide sm...FoundayoOrforglipron (small-molecule GLP-1 agonist)Wegovy+1
HealthDec 23, 2025FDA approves Wegovy pill for weight lossThe U.S. Food and Drug Administration has approved an oral pill version of Wegovy, a widely used weight-loss drug, making it the first daily oral medication for obes...FDAWegovyObesity+2
HealthFeb 24, 2026Novo Nordisk to slash Wegovy and Ozempic prices starting in 2027Novo Nordisk, a major pharmaceutical company, announced it will reduce the prices of its popular weight-loss and diabetes medications, Wegovy and Ozempic, by up to 5...Weight LossDiabetesNovo Nordisk+2
